Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Rae Ellen Bichell and Virginia Garcia...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network

Advertisement

News
RSV Burden in US Adults Substantial, Study Finds
10/03/2023
Jolynn Tumolo
Incidence rates and costs of medically attended respiratory syncytial virus (RSV) infection in US adults were highest in those aged 60 and older and those younger than 60 with preexisting cardiopulmonary or immune conditions, according to a...
Incidence rates and costs of medically attended respiratory syncytial virus (RSV) infection in US adults were highest in those aged 60 and older and those younger than 60 with preexisting cardiopulmonary or immune conditions, according to a...
Incidence rates and costs of...
10/03/2023
Pharmacy Learning Network
News
Assessing Authorized Generics’ Impact on Drug Costs: Entacapone Market Study
10/02/2023
Hannah Musick
This study examines the case of entacapone, a Parkinson disease treatment, and how the use of authorized generics (AGs) instead of independent generics (IGs) can impact brand-name exclusivity and generic competition, resulting in increased...
This study examines the case of entacapone, a Parkinson disease treatment, and how the use of authorized generics (AGs) instead of independent generics (IGs) can impact brand-name exclusivity and generic competition, resulting in increased...
This study examines the case of...
10/02/2023
Pharmacy Learning Network
News
Florida Foster Kids Are Given Powerful Medications, but Feds Find State Oversight Lacking
09/29/2023

Christopher O’Donnell, Tampa Bay Times

Christopher O’Donnell, Tampa Bay Time...
A federal audit of 115 records of children prescribed those medications selected at random by the U.S. Department of Health and Human Services found lax record-keeping and multiple cases of child welfare workers failing to follow Florida...
A federal audit of 115 records of children prescribed those medications selected at random by the U.S. Department of Health and Human Services found lax record-keeping and multiple cases of child welfare workers failing to follow Florida...
A federal audit of 115 records...
09/29/2023
Pharmacy Learning Network

Advertisement

News
Half of Medicare Patients Develop Complications After RSV Infection
09/28/2023
Jolynn Tumolo
Nearly half of Medicare-insured patients with medically attended respiratory syncytial virus experienced complications within a month of their RSV diagnosis, according to a study published online in Open Forum Infectious Diseases.
Nearly half of Medicare-insured patients with medically attended respiratory syncytial virus experienced complications within a month of their RSV diagnosis, according to a study published online in Open Forum Infectious Diseases.
Nearly half of Medicare-insured...
09/28/2023
Pharmacy Learning Network
News
OTC Sunscreens Recalled
09/28/2023
Jolynn Tumolo
Humanrace is recalling more than a dozen lots of sunscreen because of subpotency.
Humanrace is recalling more than a dozen lots of sunscreen because of subpotency.
Humanrace is recalling more than...
09/28/2023
Pharmacy Learning Network
News
Class I Recall for Immunosuppressant
09/28/2023
Jolynn Tumolo
A Class I recall has been issued for a single lot of Sandimmune Oral Solution (cyclosporine oral solution) because of product crystallization and the subsequent potential for incorrect cyclosporine dosing.
A Class I recall has been issued for a single lot of Sandimmune Oral Solution (cyclosporine oral solution) because of product crystallization and the subsequent potential for incorrect cyclosporine dosing.
A Class I recall has been issued...
09/28/2023
Pharmacy Learning Network

Advertisement

News
Early Intervention Strategies to Combat the Opioid Epidemic
09/27/2023
Hannah Musick
“The opioid epidemic is proving to be one of the costliest and most challenging public health problems of our time,” said researchers.
“The opioid epidemic is proving to be one of the costliest and most challenging public health problems of our time,” said researchers.
“The opioid epidemic is proving...
09/27/2023
Pharmacy Learning Network
News
Roughly 400,000 Cartons of a Preoperative Antiseptic Recalled for Incorrect Expiry Dates
09/25/2023
Jolynn Tumolo
The FDA has issued a Class II recall for a preoperative skin preparation antiseptic solution used to reduce bacteria that could potentially cause skin infection.
The FDA has issued a Class II recall for a preoperative skin preparation antiseptic solution used to reduce bacteria that could potentially cause skin infection.
The FDA has issued a Class II...
09/25/2023
Pharmacy Learning Network
News
Parkinson Drug Recalled
09/23/2023
Jolynn Tumolo
The FDA is recalling a prescription drug indicated for the treatment of Parkinson disease.
The FDA is recalling a prescription drug indicated for the treatment of Parkinson disease.
The FDA is recalling a...
09/23/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use